Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hosam A. Hasan
Capecitabine and Oxaliplatin Versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients With Locally Advanced Rectal Carcinoma: A Comparative Study
Journal of Cancer Therapy
Related publications
Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Erratum To: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients With Locally Advanced Rectal Cancer
Clinical Pharmacokinetics
Pharmacology
A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer
European Journal of Surgical Oncology
Medicine
Oncology
Surgery
Comparison of Capecitabine and 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Pancreatic Cancer
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome
Clinical Colorectal Cancer
Oncology
Gastroenterology
Prospective Study of Neoadjuvant Chemoradiotherapy Using Intensity-Modulated Radiotherapy and 5 Fluorouracil for Locally Advanced Rectal Cancer &Ndash; Toxicities and Response Assessment
Cancer Management and Research
Oncology
Can Diffusion-Weighted MRI Determine Complete Responders After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer?
Diagnostic and Interventional Radiology
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
BACCHUS: A Randomised Non-Comparative Phase II Study of Neoadjuvant Chemotherapy (NACT) in Patients With Locally Advanced Rectal Cancer (LARC)
Heliyon
Multidisciplinary
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology